Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Omicron adopts a different strategy from Delta and other variants to adapt to host

10 Feb 2022

Abstract excerpt

With the ongoing of Corona Virus Disease 2019 (COVID-19) epidemic, new strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are continuously emerging. After Delta (B.1.617.2) identified in India, Lambda (C.37), Mu (B.1.621), and Omicron (B.1.1.529) were successively found in Peru, Colombia, and Botswana/South Africa, and subsequently defined as variant of interest (VOI) or variant of concern...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 35145066
DOI: 10.1038/s41392-022-00903-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Omicron adopts a different strategy from Delta and other variants to adapt to hostPMID 35145066Read ↗

Evolutionary characteristics of SARS-CoV-2 Omicron subvariants adapted to the hostSemantic proximity Read ↗

The Delta and Omicron Variants of SARS-CoV-2: What We Know So FarSemantic proximity Read ↗

Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variantSemantic proximity Read ↗

Clinical and experimental evidence suggest omicron SARS-CoV-2 is inherently less pathogenic than delta independent of previous immunitySemantic proximity Read ↗

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!Semantic proximity Read ↗

Omicron (B.1.1.529) variant: Development, dissemination, and dominanceSemantic proximity Read ↗

Host Chitinase 3-like-1 is a Universal Therapeutic Target for SARS-CoV-2 Viral Variants in COVID 19Semantic proximity Read ↗

The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variantSemantic proximity Read ↗

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunitySemantic proximity Read ↗

Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?Semantic proximity Read ↗

The SARS-CoV-2 Mu variant should not be left aside: It warrants attention for its immuno-escaping ability.Semantic proximity Read ↗

SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.